Oncostellae
PrivateLast Round
Grant
Jul 1, 2025
Est. Valuation
$18.85M
Total Funding Raised
$3.25M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Oncostellae is a biotechnology company that develops small-molecule drugs for the treatment of oncology and inflammatory/autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oncostellae Comparables
Compare Oncostellae with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ability Pharmaceuticals | 85% | |
| Leukos Biotech | 84% | |
| Palobiofarma S.L. | 83% | |
Oncostellae Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2025 | ||||
| VC Round | Mar 18, 2024 | ||||
| VC Round | Jul 5, 2023 | ||||
| VC Round | Nov 22, 2022 | ||||
| VC Round | Jun 1, 2019 | ||||
Series A | Jul 23, 2017 |
Key People
Founding team and executive leadership
Oncostellae Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noso Capital | VC Round |
| Inveready | VC Round, Seed, Series A |
| Unirisco Galicia | VC Round, Series A |
| Center for Technological Development and Innovation | VC Round, Grant |
| Xesgalicia | VC Round, Seed, Series A |
| Fitalent | VC Round |
| Capital Cell | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 4132% MoM, from 38 to 1.6K.
- Mar 18, 2024
$540K raised from biotechsmartcapital, Noso Capital, and Center for Technological Development and Innovation.
Oncostellae Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oncostellae's valuation, stock price, and market status.